AAAAAA
Results:
1-24
|
Results: 24
Authors:
Skarlos, DV
Samantas, E
Briassoulis, E
Panoussaki, E
Pavlidis, N
Kalofonos, HP
Kardamakis, D
Tsiakopoulos, E
Kosmidis, P
Tsavdaridis, D
Tzitzikas, J
Tsekeris, P
Kouvatseas, G
Zamboglou, N
Fountzilas, G
Citation: Dv. Skarlos et al., Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG), ANN ONCOL, 12(9), 2001, pp. 1231-1238
Authors:
Christodoulou, C
Bafaloukos, D
Kosmidis, P
Samantas, E
Bamias, A
Papakostas, P
Karabelis, A
Bacoyiannis, C
Skarlos, DV
Citation: C. Christodoulou et al., Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases, ANN ONCOL, 12(2), 2001, pp. 249-254
Authors:
Fountzilas, G
Tsavdaridis, D
Kalogera-Fountzila, A
Christodoulou, C
Timotheadou, E
Kalofonos, C
Kosmidis, P
Adamou, A
Papakostas, P
Gogas, H
Stathopoulos, G
Razis, E
Bafaloukos, D
Skarlos, D
Citation: G. Fountzilas et al., Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer - A Hellenic Cooperative Oncology Group phase IIstudy, ANN ONCOL, 12(11), 2001, pp. 1545-1551
A modified mutagenic PCR-RFLP method for K-ras codon 12 and 13 mutations detection in NSCLC patients
Authors:
Hatzaki, A
Razi, E
Anagnostopoulou, K
Iliadis, K
Kodaxis, A
Papaioannou, D
Labropoulos, S
Vasilaki, M
Kosmidis, P
Saetta, A
Mihalatos, M
Nasioulas, G
Citation: A. Hatzaki et al., A modified mutagenic PCR-RFLP method for K-ras codon 12 and 13 mutations detection in NSCLC patients, MOL CELL PR, 15(5), 2001, pp. 243-247
Authors:
Razis, E
Dimopoulus, AM
Bafaloukos, D
Papadimitriou, C
Kalogera-Fountzila, A
Kalofonos, H
Briassoulis, E
Samantas, E
Keramopoulos, A
Pavlidis, N
Kosmidis, P
Fountzilas, G
Citation: E. Razis et al., Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer, CANCER INV, 19(2), 2001, pp. 137-144
Authors:
Fountzilas, G
Papadimitriou, C
Dafni, U
Bafaloukos, D
Skarlos, D
Moulopouos, LA
Razis, E
Kalofonos, HP
Aravantinos, G
Briassoulis, E
Papakostas, P
Abela, K
Gogas, E
Kosmidis, P
Pavlidis, N
Dimopoulos, MA
Citation: G. Fountzilas et al., Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: A randomized study conducted by the Hellenic Cooperative Oncology Group, J CL ONCOL, 19(8), 2001, pp. 2232-2239
Authors:
Choi, N
Baumann, M
Flentjie, M
Kellokumpu-Lehtinen, P
Senan, S
Zamboglou, N
Kosmidis, P
Citation: N. Choi et al., Predictive factors in radiotherapy for non-small cell lung cancer: presentstatus, LUNG CANC, 31(1), 2001, pp. 43-56
Authors:
Tsavaris, N
Skarlos, D
Bacoyiannis, C
Aravantinos, G
Kosmas, C
Retalis, G
Panopoulos, C
Vadiaka, M
Dimitrakopoulos, A
Kostantinidis, K
Mitropoulos, D
Bougas, D
Pantazopoulos, D
Kosmidis, P
Citation: N. Tsavaris et al., Combined treatment with low-dose interferon plus vinblastine is associatedwith less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma, J INTERF CY, 20(8), 2000, pp. 685-690
Authors:
Kosmidis, P
Mylonakis, N
Skarlos, D
Samantas, E
Dimopoulos, M
Papadimitriou, C
Kalophonos, C
Pavlidis, N
Nikolaidis, C
Papaconstantinou, C
Fountzilas, G
Citation: P. Kosmidis et al., Paclitaxel (175 mg/m(2)) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m(2))plus carboplatin (6 AUG) in advanced non-small-cell lung cancer (NSCLC): A multicenter randomized trial, ANN ONCOL, 11(7), 2000, pp. 799-805
Authors:
Nicolaides, C
Dimopoulos, MA
Samantas, E
Bafaloukos, D
Kalofonos, C
Fountzilas, G
Razi, E
Kosmidis, P
Pavlidis, N
Citation: C. Nicolaides et al., Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: A phase II study conducted by the Hellenic Cooperative Oncology Group, ANN ONCOL, 11(7), 2000, pp. 873-875
Authors:
Aravantinos, G
Dimopoulos, MA
Kosmidis, P
Bafaloukos, D
Papadimitriou, C
Kiamouris, C
Pavlidis, N
Sikiotis, K
Papakostas, P
Skarlos, DV
Citation: G. Aravantinos et al., Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistantpaclitaxel-pretreated ovarian cancer, ANN ONCOL, 11(5), 2000, pp. 607-612
Authors:
Samantas, E
Kalofonos, H
Linardou, H
Nicolaides, C
Mylonakis, N
Fountzilas, G
Kosmidis, P
Skarlos, D
Citation: E. Samantas et al., Phase II study of pegylated liposomal doxorubicin: Inactive in recurrent small-cell lung cancer - A Hellenic Cooperative Oncology Group Study, ANN ONCOL, 11(11), 2000, pp. 1395-1397
Authors:
Kosmidis, P
Citation: P. Kosmidis, Paclitaxel/carboplatin vs paclitaxel/gemcitabine in advanced non-small-cell lung cancer. (vol 14, pg 42, 2000), ONCOLOGY-NY, 14(11), 2000, pp. 1521-1521
Authors:
Janinis, J
Giannakakis, T
Athanasiades, A
Fountzilas, G
Bafaloukos, D
Kosmidis, P
Nikolaides, K
Pavlidis, N
Skarlos, D
Citation: J. Janinis et al., A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group study, TUMORI, 86(1), 2000, pp. 37-41
Authors:
Tsavaris, N
Kosmas, C
Mylonakis, N
Bacoyiannis, C
Kalergis, G
Vadiaka, M
Boulamatsis, D
Iakovidis, V
Kosmidis, P
Citation: N. Tsavaris et al., Parameters that influence the outcome of nausea and emesis in cisplatin based chemotherapy, ANTICANC R, 20(6C), 2000, pp. 4777-4783
Authors:
Kosmidis, P
Mylonakis, N
Dimopoulos, A
Pavlidis, N
Fountzilas, G
Samantas, E
Dimitriadis, K
Kalophonos, C
Tsavdaridis, D
Skarlos, D
Citation: P. Kosmidis et al., Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: A phase III randomized study. Preliminary results, SEMIN ONCOL, 27(1), 2000, pp. 3-8
Authors:
Fountzilas, G
Zisiadis, A
Dafni, U
Konstantaras, C
Hatzitheoharis, G
Papavramidis, S
Bousoulegas, A
Basdanis, G
Giannoulis, E
Dokmetzioglou, J
Katsohis, C
Nenopoulou, E
Karvounis, N
Briassoulis, E
Aravantinos, G
Kosmidis, P
Skarlos, D
Pavlidis, N
Citation: G. Fountzilas et al., Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvanttreatment, in patients with high-risk colon cancer - A randomized phase III study conducted by the Hellenic Cooperative Oncology Group, ONCOL-BASEL, 58(3), 2000, pp. 227-236
Authors:
Aravantinos, G
Skarlos, DV
Kosmidis, P
Georgoulias, V
Sgouros, I
Bafaloukos, D
Androulakis, N
Florou, S
Fountzilas, G
Citation: G. Aravantinos et al., Irinotecan (CPT-11) in patients with advanced colorectal cancer previouslytreated with 5-fluorouracil-based chemotherapy, CR R ONC H, 32(3), 1999, pp. 209-219
Authors:
Fountzilas, G
Zisiadis, A
Dafni, U
Konstantaras, C
Hatzitheoharis, G
Liaros, A
Athanassiou, E
Dombros, N
Dervenis, C
Basdanis, G
Gamvros, O
Souparis, A
Briasoulis, E
Samantas, E
Kappas, A
Kosmidis, P
Skarlos, D
Pavlidis, N
Citation: G. Fountzilas et al., Postoperative radiation and concomitant bolus fluorouracil with or withoutadditional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: A randomized phase III study conducted by the Hellenic Cooperative Oncology Group, ANN ONCOL, 10(6), 1999, pp. 671-676
Authors:
Fountzilas, G
Stathopoulos, G
Nicolaides, C
Kalogera-Fountzila, A
Kalofonos, H
Nikolaou, A
Bacoyiannis, C
Samantas, E
Papadimitriou, C
Kosmidis, P
Daniilidis, J
Pavlidis, N
Citation: G. Fountzilas et al., Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group, ANN ONCOL, 10(4), 1999, pp. 475-478
Authors:
Dimopoulos, MA
Bakoyannis, C
Georgoulias, V
Papadimitriou, C
Moulopoulos, LA
Deliveliotis, C
Karayannis, A
Varkarakis, I
Aravantinos, G
Zervas, A
Pantazopoulos, D
Fountzilas, G
Bamias, A
Kyriakakis, Z
Anagnostopoulos, A
Giannopoulos, A
Kosmidis, P
Citation: Ma. Dimopoulos et al., Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: A multicenter phase II study of the Hellenic Cooperative Oncology Group, ANN ONCOL, 10(11), 1999, pp. 1385-1388
Authors:
Samantas, E
Skarlos, DV
Pectasides, D
Nicolaides, P
Kalofonos, H
Mylonakis, N
Vardoulakis, T
Kosmidis, P
Pavlidis, N
Fountzilas, G
Citation: E. Samantas et al., Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer, LUNG CANC, 23(2), 1999, pp. 159-168
Authors:
Pectasides, D
Aravantinos, G
Visvikis, A
Bakoyiannis, C
Halikia, A
Kalofonos, C
Kosmidis, P
Skarlos, D
Fountzilas, G
Citation: D. Pectasides et al., Platinum-based chemotherapy of primary extragonadal germ cell tumours: TheHellenic Cooperative Oncology Group experience, ONCOL-BASEL, 57(1), 1999, pp. 1-9
Authors:
Bafaloukos, D
Aravantinos, G
Samonis, G
Katsifis, G
Bakoyiannis, C
Skarlos, D
Kosmidis, P
Citation: D. Bafaloukos et al., Carboplatin, methotrexate and 5-fluorouracil in combination with medroxyprogesterone acetate (JMF-M) in the treatment of advanced or recurrent endometrial carcinoma: A Hellenic Cooperative Oncology Group Study, ONCOL-BASEL, 56(3), 1999, pp. 198-201
Risultati:
1-24
|